Search results
Results from the WOW.Com Content Network
Novartis AG is a publicly traded Swiss holding company that operates through the Novartis Group and owns, directly or indirectly, all companies worldwide that operate as subsidiaries of the Novartis Group. [110] Novartis's businesses are divided into two operating divisions: Innovative Medicines and Sandoz (generics). [111]
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Syngenta was founded in 2000 by the merger of the agrichemical businesses of Novartis and AstraZeneca, and acquired by China National Chemical Corporation (ChemChina) in 2017. [3] In 2020, the Syngenta Group was formed, bringing together Syngenta Crop Protection and Syngenta Seeds, Adama , and the agricultural business of Sinochem , now called ...
Novartis: Vasant Narasimhan: CEO 2017 Former engineer for Public Service Enterprise Group: 2017-11-12 Nintendo: Tatsumi Kimishima: Representative director and president [75] 2015 Succeeded Satoru Iwata after his death 2017-11-12 Oracle Corporation: Safra Catz: CEO [76] 2014 Co-CEO following Larry Ellison: 2017-11-12 Oracle Corporation: Mark ...
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. [4] Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz.
Jimenez joined Novartis in 2007 as Division Head of Novartis Pharmaceutical and was named CEO in 2010 [7] by his predecessor and Chairman Daniel Vasella. [8]During his time at Novartis, Jimenez increasingly applied standard business metrics to pharma cash flow, purchasing and competitive bidding, confident that his experience in consumer goods would help to realize improvements in Novartis ...
Novartis has also stated that the NITD will seek to make treatments developed by the NITD available without profit to the poor in developing nations in which these diseases are endemic. [3] In 2017, NITD moved out of Singapore to be beside Novartis' infectious diseases research headquarters in Emeryville, California, United States. [4]
Jörg Reinhardt (born 11 March 1956) is a German businessman who has been the chairman of the board of directors of the Swiss pharmaceutical group Novartis AG since 2013. [1] [2] Since 2017, he has also been a member of the board of directors of the Swiss reinsurance group Swiss Re.